TDaP ( tetanus, diphtheria, and pertussis (whooping cough))

Mar 11, 2011Clinical Trial, Uncategorized, Vaccines

If you have a healthy child 10 or 11 years of age, he/she may qualify for a clinical vaccine testing to protect against tetanus, diphtheria, and pertussis (whooping cough) research trial to evaluate the safety of vaccine. This vaccine is already FDA approved in children and adults 11 and older. The main purpose of this study is to see if this vaccine works just as well with children that are 10 years old as compared to those that are 11 years old.
Basic qualifications are:

10 & 11 years of age
Male or Female
Healthy
Must have a documented vaccination history of receiving 5 previous doses of DTaP vaccine

If you qualify you may receive:

Study related exam
No cost investigational Tdap vaccination
Compensation up to $200 for time and travel

Go to our website and fill out the form to see if your child may be a candidate for this study.

Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.

Our clinical operations continue, and we have implemented the following additional safety measures:

Enhanced screening of everyone entering any of our facilities before they are admitted into our offices or clinical areas
Reinforced internal communication regarding the COVID-19 situation, CDC and SHRM recommendations, digital team meetings, and the importance of using sick leave for anyone who has signs, symptoms, or recent exposure to someone with suspected or diagnosed COVID-19
Additional cleaning and disinfecting materials provided through our clinic and office areas
Cross-training and preparations for contingency plans if key staff need to stay home

We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.

TDaP ( tetanus, diphtheria, and pertussis (whooping cough))

Share This Resource

​Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

Update on COVID-19